Market Design

I'll post market design related news and items about repugnant markets. See also my Stanford profile. I have a general-interest book on market design: Who Gets What--and Why The subtitle is "The new economics of matchmaking and market design."

Showing posts with label challenge. Show all posts

Tuesday, October 24, 2023

Scientists deliberately gave women Zika--challenge trials for diseases whose incidence has dropped too far for conventional clinical trials

›

Nature has the story (despite the somewhat inflammatory headline). Scientists deliberately gave women Zika — here’s why. ‘Human challenge’...

Friday, September 22, 2023

Support for hepatitis C human challenge studies, in The Lancet Gastroenterology & Hepatology

›

Here's a call for action, in The Lancet Gastroenterology & Hepatology: Joint statement in support of hepatitis C human challenge st...

Saturday, August 26, 2023

Challenge trials for a Hepatitis C vaccine

›

The Journal Clinical Infectious Diseases has a special supplement on challenge trials (human infection trials) of a Hep C vaccine (now tha...

Saturday, June 24, 2023

Challenge trial for Covid in England reveals airborne superspreaders

›

Nature has a news story about a Lancet Microbe paper reporting the challenge trial. See links to and excerpts from both below. Here's...

Saturday, February 18, 2023

Compensation for participating in clinical trials

›

Here's an opinion piece from Medpage Today: It's Time to Pay Clinical Trial Participants More — Accelerating trial enrollment can ...

›

Home

View web version

About Me

Al Roth

View my complete profile